Have you ever treated a patient with hyperoxaluria? What do you need to know about this liver-generated disease process to effectively provide patient care? Long-term management may consist of a combined liver-kidney transplant. This session reviews the specific transplant evaluation criteria for this difficult disease and the outcomes data for individuals who receive dual transplants as a result of hyperoxaluria.
Contact hours available until 4/24/2015
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Faculty, Planners and Authors Conflict of Interest Disclosure: Planning Committee: Kristin Larson – Consultant, Nephrology Clinical Solutions; Employee, Affymax; Other financial support, Kristin M. Larson, RN, MSN, LLC; Sandy Bodin – Employee, Affymax; Dawn Koonkongsatian – Employee, Fresenius Medical Care; Elizabeth St. John - Employee, Fresenius Medical Care
Presenter(s) have no disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declare.
Non-Endorsement of Products: Accreditation of activities for contact hours does not imply approval or endorsement of any product, advertising, or educational content by ANNA or the American Nurses Credentialing Center’s Commission on Accreditation.
Accreditation Statement: American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.
Objectives: • Discuss the incidence, etiology, pathophysiology, and clinical presentation of hyperoxaluria. • Describe diagnosis, treatment options, and long-term management of hyperoxaluria • Explain the evaluation process for combined liver-kidney transplantation. • Review outcomes data from the UCSF experience with combined liver-kidney transplantation for patients with hyperoxaluria.